ethyl 4-{[(quinoline-3-yl)methyl]amino}benzoate | 25927-76-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: ethyl 4-{[(quinoline-3-yl)methyl]amino}benzoate
• 英文别名: Ethyl-p-N-(3-quinolinylmethyl)aminobenzoate；4-(quinolin-3-ylmethyl-amino)-benzoic acid ethyl ester；ethyl 4-(quinolin-3-ylmethylamino)benzoate
• CAS: 25927-76-8
• 化学式: C₁₉H₁₈N₂O₂
• 分子量: 306.364
• InChiKey: OUGQCWQDJZPUMW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  51.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 4-{[(quinoline-3-yl)methyl]amino}benzoate 在 吡啶 、 4-二甲氨基吡啶 、 lithium hydroxide monohydrate 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 36.0h， 生成 4-{N-[(quinoline-3-yl)methyl][1,1’-biphenyl]-4-sulfonamido}benzoic acid
  参考文献：
  名称：

  Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation

  摘要：

  Leukotrienes (LTs) and prostaglandin (PG)E-2, produced by 5-lipoxygenase (5-LO) and microsomal prostaglandin E-2 synthase-1 (mPGES-1), respectively, are key players in inflammation, and pharmacological suppression of these lipid mediators (LM) represents a strategy to intervene with inflammatory disorders. Previous studies revealed that the benzenesulfonamide scaffold displays efficient 5-LO-inhibitory properties. Here, we structurally optimized benzenesulfonamides which led to an N-phenyl-benzenesulfonamide derivative (compound 47) with potent inhibitory activities (IC50 = 2.3 and 0.4 mu M for isolated 5-LO and 5-LO in intact cells, respectively). Compound 47 prevented the interaction of 5-LO with its activating protein (FLAP) at the nuclear envelope in transfected HEK293 cells as shown by in situ proximity ligation assay. Comprehensive assessment of the LM profile produced by human macrophages revealed the ability of 47 to selectively down-regulate pro-inflammatory LMs (i.e. LTs and PGE(2)) in M1 but to enhance the formation of pro-resolving LMs (i.e. resolvins and maresins) in M2 macrophages. Moreover, 47 strongly inhibited LT formation and cell infiltration in two in vivo models of acute inflammation (i.e., peritonitis and air pouch sterile inflammation in mice). Together, 47 represents a novel LT biosynthesis inhibitor with an attractive pharmacological profile as anti-inflammatory drug that also promotes the biosynthesis of pro-resolving LM. (C) 2018 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2018.07.031
• 作为产物：
  描述：

  4-quinolin-3-ylmethyleneamino-benzoic acid ethyl ester 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 以60.4%的产率得到ethyl 4-{[(quinoline-3-yl)methyl]amino}benzoate
  参考文献：
  名称：

  3-[N(4'-酰胺磺酰基)-苯基]-氨基甲基-喹啉的抗疟原虫作用的结构依赖性

  摘要：

  标题化合物 1 的结构显然是一种新的抗疟原虫作用原理，因为无论是喹啉成分、磺酰胺成分还是键的类型都不能在不显着损失有效性的情况下改变。

  DOI：

  10.1002/ardp.19803130209

文献信息

• Strukturabhängigkeit der antiplasmodischen Wirkung von 3-[N(4′-Amidosulfonyl)-phenyl]-aminomethyl-chinolin
  作者：Frauke Gaedcke、Rosemarie Knorr、Felix Zymalkowski

  DOI：10.1002/ardp.19803130209

  日期：——

  Die Struktur der Titelverbindung 1 ist offenbar ein neues antiplasmodisches Wirkungsprinzip, weil weder die Chinolinkomponente, noch der Sulfonamidanteil, noch die Art der Verknüpfung ohne erhebliche Wirkungseinbuße verändert werden dürfen.

  标题化合物 1 的结构显然是一种新的抗疟原虫作用原理，因为无论是喹啉成分、磺酰胺成分还是键的类型都不能在不显着损失有效性的情况下改变。
• Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation
  作者：Sun-Yee Cheung、Markus Werner、Lucia Esposito、Fabiana Troisi、Vincenza Cantone、Stefanie Liening、Stefanie König、Jana Gerstmeier、Andreas Koeberle、Rossella Bilancia、Roberta Rizza、Antonietta Rossi、Fiorentina Roviezzo、Veronika Temml、Daniela Schuster、Hermann Stuppner、Manfred Schubert-Zsilavecz、Oliver Werz、Thomas Hanke、Simona Pace

  DOI：10.1016/j.ejmech.2018.07.031

  日期：2018.8

  Leukotrienes (LTs) and prostaglandin (PG)E-2, produced by 5-lipoxygenase (5-LO) and microsomal prostaglandin E-2 synthase-1 (mPGES-1), respectively, are key players in inflammation, and pharmacological suppression of these lipid mediators (LM) represents a strategy to intervene with inflammatory disorders. Previous studies revealed that the benzenesulfonamide scaffold displays efficient 5-LO-inhibitory properties. Here, we structurally optimized benzenesulfonamides which led to an N-phenyl-benzenesulfonamide derivative (compound 47) with potent inhibitory activities (IC50 = 2.3 and 0.4 mu M for isolated 5-LO and 5-LO in intact cells, respectively). Compound 47 prevented the interaction of 5-LO with its activating protein (FLAP) at the nuclear envelope in transfected HEK293 cells as shown by in situ proximity ligation assay. Comprehensive assessment of the LM profile produced by human macrophages revealed the ability of 47 to selectively down-regulate pro-inflammatory LMs (i.e. LTs and PGE(2)) in M1 but to enhance the formation of pro-resolving LMs (i.e. resolvins and maresins) in M2 macrophages. Moreover, 47 strongly inhibited LT formation and cell infiltration in two in vivo models of acute inflammation (i.e., peritonitis and air pouch sterile inflammation in mice). Together, 47 represents a novel LT biosynthesis inhibitor with an attractive pharmacological profile as anti-inflammatory drug that also promotes the biosynthesis of pro-resolving LM. (C) 2018 Elsevier Masson SAS. All rights reserved.